Fulvestrant.: Treatment of breast cancer, antiestrogen.

被引：3
|
作者：
Levin, M
D'Souza, N
Castañer, J
机构：
[1] Prous Sci, Barcelona 08080, Spain
[2] Lincoln Med & Mental Hlth Ctr, Ctr Comprehens Canc, Bronx, NY 10451 USA
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 09期
关键词：
ICI-182780; ZD-9238; Faslodex (TM);
D O I：
10.1358/dof.2001.026.09.634749
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：841 / 850
页数：10
相关论文
共 50 条
  • [21] ANTIESTROGEN AND BREAST-CANCER
    METZ, R
    BEY, P
    NOUVELLE PRESSE MEDICALE, 1977, 6 (44): : 4145 - 4146
  • [22] Carboplatin treatment of antiestrogen-resistant breast cancer cells
    Larsen, Mathilde S.
    Yde, Christina W.
    Christensen, Ib J.
    Lykkesfeldt, Anne E.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (05) : 1863 - 1870
  • [23] Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant. Results from a real word setting
    Pizzuti, Laura
    Natoli, Clara
    Gamucci, Teresa
    Mauri, Mariella
    Sergi, Domenico
    Di Lauro, Luigi
    Paoletti, Giancarlo
    Ruggeri, Enzo
    Iezzi, Laura
    Sperduti, Isabella
    Mentuccia, Lucia
    Fabbri, Agnese
    Maugeri-Sacca, Marcello
    Moscetti, Luca
    Barba, Maddalena
    Vici, Patrizia
    ONCOTARGET, 2017, 8 (40) : 69025 - 69037
  • [24] Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients
    Poggio, Francesca
    Lambertini, Matteo
    Blondeaux, Eva
    Vaglica, Marina
    Levaggi, Alessia
    Pronzato, Paolo
    Del Mastro, Lucia
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (09) : 1153 - 1161
  • [25] Fulvestrant in the paliative treatment of hormone-sensitive breast Cancer
    Kolasinska-Cwikla, Agnieszka
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : F5 - F7
  • [26] Fulvestrant injection (Faslodex) - Additional treatment for advanced breast cancer
    不详
    AMERICAN JOURNAL OF NURSING, 2002, 102 (08) : 24CCC - 24CCC
  • [27] Endocrine treatment options for advanced breast cancer - the role of fulvestrant
    Robertson, JFR
    Come, SE
    Jones, SE
    Beex, L
    Kaufmann, M
    Makris, A
    Nortier, JWR
    Possinger, K
    Rutqvist, LE
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (03) : 346 - 356
  • [28] A Review of Fulvestrant in Breast Cancer
    Mark R. Nathan
    Peter Schmid
    Oncology and Therapy, 2017, 5 (1) : 17 - 29
  • [29] Palbociclib and Fulvestrant in Breast Cancer
    McCaw, Zachary R.
    Vassy, Jason L.
    Wei, Lee-Jen
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (08): : 796 - 796
  • [30] QUALITY OF LIFE RESPONSE IN WOMEN WITH ADVANCED BREAST CANCER RECEIVING FASLODEX (FULVESTRANT) AFTER PROGRESSION ON PRIOR ANTIESTROGEN THERAPY
    Novik, A. A.
    Ionova, T. I.
    Kalyadina, S. A.
    Kishtovich, A. V.
    ANNALS OF ONCOLOGY, 2008, 19 : 75 - 75
12345